KLRS
Kalaris Therapeutics, Inc. Common Stock
KLRS
KLRS
90 hedge funds and large institutions have $115M invested in Kalaris Therapeutics, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 40 increasing their positions, 20 reducing their positions, and 18 closing their positions.
Holders
90
Holders Change
-4
Holders Change %
-4.26%
% of All Funds
1.44%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
40
Reduced
20
Closed
18
Calls
$59K
Puts
$102K
Net Calls
-$43K
Net Calls Change
+$6K
Top Buyers
1 |
1
Millennium Management
New York
|
$1.6M |
2 |
2
BlackRock
New York
|
$8.27M |
3 |
WP
3
Woodline Partners
San Francisco,
California
|
$4.44M |
4 |
4
Morgan Stanley
New York
|
$1.19M |
5 |
5
Geode Capital Management
Boston,
Massachusetts
|
$2.54M |